Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 7/20 | 0.34 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.33 |
| ▸ | IARS2 | Q9NSE4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7052588 | 0.95 | LMNA (0.53) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL5030922 | 0.89 | LMNA (0.60) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9352754 | 0.87 | LMNA (0.58) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9009053 | 0.87 | LMNA (0.58) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL12871731 | 0.86 | LMNA (0.60) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL13220211 | 0.86 | LMNA (0.57) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL14087101 | 0.86 | LMNA (0.51) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL10624509 | 0.86 | LMNA (0.57) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL8378687 | 0.85 | LMNA (0.56) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL3062459 | 0.85 | LMNA (0.54) | LMNACYP2C19HIF1AEGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116421744-A | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| WO-2008104853-A1 | PROCESSES FOR THE PREPARATION OF PURE IOVERSOL | WOCKHARDT RESEARCH CENTRE (IN) | 2008-09-04 | — | — | WO | claimed |
| US-6596904-B1 | Process for producing ioversol | MALLINC KRODT INC | 2003-07-22 | — | — | US | claimed |
| EP-0839056-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2003-05-07 | — | — | EP | claimed |
| EP-0886634-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2002-04-24 | — | — | EP | claimed |
| US-5648536-A | Process for producing ioversol | LAFAYETTE PHARMACEUTICALS LLC | 1997-07-15 | — | — | US | claimed |
| CN-115093342-B | Industrial production method of ioversol | 安徽普利药业有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-117800986-A | Preparation method of ioversol impurity | 重庆圣华曦药业股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-116421744-B | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-116768747-A | Intermediate of ioversol and method for preparing ioversol | 江苏宇田医药有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116421744-A | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-115806500-A | Synthesis of ioversol polysubstituent | 大道隆达（北京）医药科技发展有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-115093342-A | Industrial production method of ioversol | 安徽普利药业有限公司 | 2022-09-23 | — | — | CN | disclosed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| US-5648536-A | Process for producing ioversol | LAFAYETTE PHARMACEUTICALS LLC | 1997-07-15 | — | — | US | disclosed |
| US-5648536-A | Process for producing ioversol | LAFAYETTE PHARMACEUTICALS LLC | 1997-07-15 | — | — | US | disclosed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0571593-B1 | NEW NON IONIC IODIZED AGENTS FOR X-RAY CONTRASTING, METHOD FOR PREPARING THEM AND GALENICAL COMPOSITIONS CONTAINING THEM | INVEST JUSTESA IMAGEN S A CENT (ES) | 1996-10-30 | — | — | EP | disclosed |